Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Niagen (nicotinamide riboside) demonstrated that oral supplementation with NR significantly increased NAD+ levels in NEVs and attenuated neurodegenerative biomarkers including Aβ42, a biomarker for Alzheimer’s disease (AD).
Lead Product(s): Nicotinamide Riboside
Therapeutic Area: Neurology Product Name: Niagen
Highest Development Status: Phase IIProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 31, 2023
Details:
Tru Niagen (nicotinamide riboside) demonstrated that oral supplementation with NR significantly increased NAD+ levels in NEVs and attenuated neurodegenerative biomarkers including Aβ42, a biomarker for Alzheimer’s disease (AD).
Lead Product(s): Nicotinamide Riboside
Therapeutic Area: Nutrition and Weight Loss Product Name: Tru Niagen
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 17, 2023
Details:
Tru Niagen (nicotinamide riboside) demonstrated that oral supplementation with NR significantly increased NAD+ levels in NEVs and attenuated neurodegenerative biomarkers including Aβ42, a biomarker for Alzheimer’s disease (AD).
Lead Product(s): Nicotinamide Riboside
Therapeutic Area: Nutrition and Weight Loss Product Name: Tru Niagen
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable December 27, 2022
Details:
The cross-border distribution strategy allows for Tru Niagen® (nicotinamide riboside) 300mg 30 count bottles, Tru Niagen® 300mg 90 count bottles and Tru Niagen® 300mg 30 count Stickpacks to be purchased by consumers looking to age healthier.
Lead Product(s): Nicotinamide Riboside
Therapeutic Area: Dermatology Product Name: Tru Niagen
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: MyPharma2Go Corporation
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership September 01, 2022
Details:
Tru Niagen®, featuring Niagen®, is one of the top-selling brands in the Vitamin B3 category on Amazon U.S. for boosting NAD+ levels. Supplementation with Niagen® is backed by 20 published and peer-reviewed clinical trials.
Lead Product(s): Nicotinamide Riboside
Therapeutic Area: Nutrition and Weight Loss Product Name: Tru Niagen
Highest Development Status: ApprovedProduct Type: Small molecule
Recipient: Sinopharm
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement June 10, 2022
Details:
Tru Niagen Immune, is a combination of ingredient Niagen (nicotinamide riboside), and Theracurmin (curcumin) is first-ever immune health supplement with a targeted NAD+ boost for the optimal maintenance and function of aging cells.
Lead Product(s): Nicotinamide Riboside
Therapeutic Area: Dermatology Product Name: Tru Niagen
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 06, 2022
Details:
A newly granted continuation patent provides additional intellectual property protection for ChromaDex’s Niagen (nicotinamide riboside) ingredient and other nicotinamide adenine dinucleotide (NAD) precursors.
Lead Product(s): Nicotinamide Riboside
Therapeutic Area: Dermatology Product Name: Niagen
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 16, 2022
Details:
Results of phase I clinical trial for Niagen, showed that NR supplementation significantly increased cerebral nicotinamide adenine dinucleotide levels, and resulted in altered cerebral energy metabolism and decreased levels of inflammatory cytokines in patients with PD.
Lead Product(s): Nicotinamide Riboside
Therapeutic Area: Neurology Product Name: Niagen
Highest Development Status: Phase IIProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 02, 2022
Details:
Niagen® replenishes levels of NAD+, supports healthy cellular metabolism, and helps mitochondria function more eciently to promote healthy aging at the cellular level.
Lead Product(s): Nicotinamide Riboside
Therapeutic Area: Ophthalmology Product Name: Niagen
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 31, 2022
Details:
ChromaDex’s proprietary healthy aging ingredient Niagen®, the world’s first and only FDA-safety reviewed and patented form of nicotinamide riboside, will be added to multi-ingredient Designs for Health formulas.
Lead Product(s): Nicotinamide Riboside
Therapeutic Area: Dermatology Product Name: Niagen
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Designs for Health
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement January 20, 2022